W. A. M. Duncan - Concepedia

Author

W. A. M. Duncan

Also Known As

W A Duncan, W A M Duncan, W Duncan, W. A. Duncan, W. A. M. DUNCAN, W. A. M. Duncan, W. A.M. DUNCAN, W.A.M. DUNCAN, W.A.M. Duncan, WAM Duncan

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United Kingdom)

About

W. A. M. Duncan is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	3.8K
2	Allergy	3	3	455
3	Anesthesia	1	1	79
4	Biochemistry	1	1	11
5	Biomedical Engineering	1	1	28

W. A. M. Duncan

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Definition and Antagonism of Histamine H2-receptors J. W. Black, W. A. M. Duncan, C. J. DURANT, Nature Signal TransductionMolecular PhysiologyMedicineHistamine H2-receptorsMechanism Of Action	1972	2.3K
Cimetidine—A Non-Thiourea H<sub>2</sub>-Receptor Antagonist R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, Journal of International Medical Research Molecular PharmacologyPharmacological StudyMedicine-Receptor AntagonistMechanism Of Action	1975	450
Metiamide — An orally active histamine H2-receptor antagonist J. W. Black, W. A. M. Duncan, J. C. EMMETT, Inflammation Research Molecular PharmacologyMedicineMetiamide —Mechanism Of ActionPharmacological Agent	1973	258
Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors G. J. DURANT, W. A. M. Duncan, C. Robin Ganellin, Nature AllergyFunctional SelectivitySpecific AgonistF 92676Medicine	1978	222
Characterization and development of cimetidine as a histamine H2-receptor antagonist R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, Gastroenterology AllergyMedicineMechanism Of ActionPharmacological AgentHistamine H2-receptor Antagonist	1978	202
Absorption and Distribution of Drugs W. A. M. Duncan Nature Drug PurityPharmacologyDrug AbsorptionMedicineDrug Class	1964	127
THE PHARMACOKINETICS OF HALOTHANE (FLUOTHANE) ANAESTHESIA W. A. M. Duncan, J. RAVENTÓS British Journal of Anaesthesia MedicineAnesthesia PracticePharmacotherapyPharmacokinetics Of HalothaneAnesthesia	1959	79
The pharmacology of cimetidine, a new histamine H<sub>2</sub>‐receptor antagonist RW Brimblecombe, W. A. M. Duncan, GJ Durant, British Journal of Pharmacology Molecular PharmacologyCompetitive AntagonismPharmacological StudyMedicineBehavioral Pharmacology	2010	73
Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist. R.W. Brimblecombe, W. A. M. Duncan, G. J. DURANT, PubMed Central Molecular PharmacologyPharmacological StudyMedicinePharmacological AgentClinical Pharmacology	1975	41
The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists. R.W. Brimblecombe, W. A. M. Duncan, D. A. A. Owen, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) Molecular PharmacologyCompetitive AntagonismAllergyPharmacological StudyGastrointestinal Pharmacology	1976	31

Page 1